首页> 美国卫生研究院文献>Frontiers in Neurology >Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment
【2h】

Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment

机译:成人干细胞和诱导性多能干细胞用于中风治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stroke is the main cause of disability and death in the world within neurological diseases. Despite such a huge impact, enzymatic, and mechanical recanalization are the only treatments available so far for ischemic stroke, but only <20% of patients can benefit from them. The use of stem cells as a possible cell therapy in stroke has been tested for years. The results obtained from these studies, although conflicting or controversial in some aspects, are promising. In the last few years, the recent development of the induced pluripotent stem cells has opened new possibilities to find new cell therapies against stroke. In this review, we will provide an overview of the state of the art of cell therapy in stroke. We will describe the current situation of the most employed stem cells and the use of induced pluripotent stem cells in stroke pathology. We will also present a summary of the different clinical trials that are being carried out or that already have results on the use of stem cells as a potential therapeutic intervention for stroke.
机译:中风是导致神经系统疾病致残和死亡的主要原因。尽管产生了如此巨大的影响,但酶促和机械再通是迄今为止针对缺血性中风的唯一可用疗法,但只有不到20%的患者可以从中受益。使用干细胞作为中风的一种可能的细胞疗法已经测试了多年。尽管在某些方面存在冲突或争议,但从这些研究中获得的结果还是很有希望的。在最近几年中,诱导的多能干细胞的最新发展为寻找新的抗中风细胞疗法开辟了新的可能性。在这篇综述中,我们将概述卒中细胞治疗的最新技术水平。我们将描述最常用的干细胞的现状以及在卒中病理中诱导多能干细胞的使用。我们还将概述正在进行的不同临床试验的结果,或者已经将使用干细胞作为中风的潜在治疗手段取得了成果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号